This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BlackRock Inc., headquartered in New York, offers products that span the risk spectrum, including active, enhanced and index strategies through a variety of structures that include separate accounts, mutual funds, iShares exchange traded funds (ETFs) and other pooled investment vehicles.
Ameriprise (AMP) Q3 Earnings Beat, Revenues Rise Marginally
by Zacks Equity Research
Ameriprise (AMP) witnesses higher revenues and lower expenses in the third quarter of 2019.
T. Rowe Price (TROW) Q3 Earnings Top Estimates, AUM Escalates
by Zacks Equity Research
T. Rowe Price's (TROW) Q3 results reflect higher assets under management (AUM) and revenues, partly offset by elevated expenses.
SEI Investments (SEIC) Beats on Q3 Earnings, Revenues Grow
by Zacks Equity Research
SEI Investments (SEIC) witnesses higher revenues and lower expenses in the third quarter of 2019.
Invesco (IVZ) Q3 Earnings Beat on Higher Revenues & Assets
by Zacks Equity Research
Rise in revenues and assets balance aid Invesco's (IVZ) Q3 earnings. However, higher expenses pose a concern.
Investment Managers' Earnings on Oct 23: IVZ, RJF, BX & More
by Swayta Shah
Results of investment management stocks are likely to reflect modest asset inflows amid challenging operating environment.
Cohen & Steers' (CNS) Q3 Earnings Beat on Higher Revenues
by Zacks Equity Research
Improving assets balance and increase in revenues support Cohen & Steers' (CNS) Q3 earnings.
Company News For Oct 16, 2019
by Zacks Equity Research
Companies In The News Are: WWR, WFC, BLK and PUYI
BlackRock (BLK) Beats Q3 Earnings Estimates
by Zacks Equity Research
BlackRock (BLK) delivered earnings and revenue surprises of 2.88% and -1.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
BlackRock (BLK) Q3 Earnings Beat Estimates as Revenues Rise
by Zacks Equity Research
BlackRock (BLK) witnesses growth in revenues in the third quarter of 2019. However, higher costs hurt results to some extent.
Why Earnings Beat is Less Likely for BlackRock (BLK) in Q3
by Zacks Equity Research
While steady iShares inflows are expected to have aided BlackRock's (BLK) assets under management in the third quarter of 2019, higher costs might have hurt results to some extent.
Are You Looking for a High-Growth Dividend Stock? BlackRock (BLK) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes? Let's find out.
Earnings Preview: BlackRock (BLK) Q3 Earnings Expected to Decline
by Zacks Equity Research
BlackRock (BLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BlackRock Eyes Partnership With Tencent to Expand in China
by Zacks Equity Research
BlackRock (BLK) is in preliminary talks with Tencent over the past year to develop a partnership in an effort to expand in the China mutual fund market.
BlackRock (BLK) Rides on Asset Growth Despite High Costs
by Zacks Equity Research
While solid AUM balance is expected to support BlackRock's (BLK) revenue growth, higher costs will likely hurt the bottom line.
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
This is Why BlackRock (BLK) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes? Let's find out.
Top Stock Reports for Facebook, UnitedHealth & GlaxoSmithKline
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth Group (UNH) and GlaxoSmithKline (GSK).
Why BlackRock (BLK) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes? Let's find out.
Eaton Vance (EV) Rallies 2.7% on Q3 Earnings Beat, Costs Up
by Zacks Equity Research
Rise in assets balance and a modest growth in revenues support Eaton Vance's (EV) fiscal Q3 earnings.
Are You Looking for a High-Growth Dividend Stock? BlackRock (BLK) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes? Let's find out.
BlackRock (BLK) Down 11.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
BlackRock (BLK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BlackRock Buys Stake in Authentic Brands: How Should Investors React?
by Mitchell Moore
On Sunday, August 11th, BlackRock (BLK) announced that it would be purchasing a roughly 30% stake in privately held Authentic Brands for $875 million, a deal that values the company at over $4 billion. Shares closed down 2.62% in trading Monday.
Why BlackRock (BLK) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes? Let's find out.
Moelis & Company (MC) Beats on Q2 Earnings as Costs Decline
by Zacks Equity Research
Moelis & Company (MC) witnesses lower revenues and expenses in the second quarter of 2019.
Waddell & Reed (WDR) Beats on Q2 Earnings as Expenses Fall
by Zacks Equity Research
Lower operating expenses support Waddell & Reed's (WDR) Q2 earnings amid net outflows.